Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-ASSIST: Cannabidiol Augmentation of Clozapine in Treatment Resistant Psychosis
NCT07326124Phase 3Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Jan 2027
- Primary completion
- Sep 2028
- Countries
- 8
01
Overview
A Phase 3 trial of cannabidiol in psychosis, sponsored by University of Oxford. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT07326124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07326124.